Picture of bioXXmed AG logo

T5O0 bioXXmed AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: CytoTools Announces Confirmed Efficacy Of DPOCL In COVID-19

Nov 13 (Reuters) - CYTOTOOLS AG  T5OG.DE :
    * EFFICACY OF DPOCL IN COVID-19 CONFIRMED BY THE INSTITUTE
OF
MEDICAL VIROLOGY AT FRANKFURT UNIVERSITY HOSPITAL
    * TEST RESULTS CONFIRM CLEARLY VIRUCIDAL ("VIRUS-KILLING")
EFFECT
OF ACTIVE INGREDIENT ON COVID-19-TRIGGERING SARS-COV-2 PATHOGEN
    * SEARCH FOR PROJECT PARTNER FOR FAST TRACK APPROVAL AND
MARKET
LAUNCH STARTED
    * WE HOPE TO FINALIZE THE SEARCH ALREADY IN Q1 OF 2021 IN
ORDER TO
START APPROVAL PROCESS AS SOON AS POSSIBLE

Source text for Eikon:  ID:nEQb3fLw5a 
Further company coverage:  T5OG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on bioXXmed AG

See all news